Universidad Privada Sergio Bernales
- h-index: 15
- Total citations: 2,551
- Total papers: 109
Recent papers from Universidad Privada Sergio Bernales
- In vitro susceptibility testing of aztreonam-avibactam against predominantly NDM-producing Enterobacterales in PeruMicrobiology Spectrum · 2026
- Clinical Characteristics of Mpox and Mpox– HIV Coinfection in Lima, Peru: A Retrospective Multicenter AnalysisTropical Medicine & International Health · 2026
- Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosisClinical Infectious Diseases · 2026
- Cardiomyopathies of endocrine origin: A state-of-the-art reviewWorld Journal of Cardiology · 2025
- Smartphone dependence, addiction, and insomnia among medical students during the COVID-19 pandemicPLoS ONE · 2025
- Prevalence and factors associated with physical activity in adolescents from five secondary schools in northern PeruBMC Public Health · 2025
- Epidemiological and clinical characteristics of Peruvian patients with mpox: A systematic review and meta-analysisPLoS ONE · 2025
- Prevalence of dengue in febrile patients in Peru: A systematic review and meta-analysisPLoS ONE · 2025
- Influence of Behavioral and Psychological Symptoms on Caregiver Burden for Different Types of Dementia: Clinical Experience in Lima, PeruDementia and Geriatric Cognitive Disorders · 2024
- Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trialTrials · 2023
- Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed DrugsClinical Infectious Diseases · 2023
- Diabetic neuropathy: Past, present, and future.2023
- Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line DrugsClinical Infectious Diseases · 2022
- Quality Improvement to Address Surgical Burden of Disease at a Large Tertiary Public Hospital in PeruWorld Journal of Surgery · 2021
- Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trialThe Lancet Respiratory Medicine · 2019
- Towards the generation of dry patient‐specific human aortic valve models from medical imaging dataPAMM · 2018
- Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine · 2018
- Development of patient‐specific computational models of the human aortic valve under healthy and diseased conditionsPAMM · 2017
- Improving tuberculosis diagnostics using deep learning and mobile health technologies among resource-poor communities in PerúSmart Health · 2017
- Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trialBMC Infectious Diseases · 2016